Showing 181-200 of 644 for: Cochrane Systematic Reviews > Psychiatric and substance abuse 
- Desmopressin for nocturnal enuresis in children
Cochrane Systematic Reviews, 5-Nov-2008
Enuresis (bed-wetting) is a socially disruptive and stressful condition which affects from 15% to 20% of five year olds, and up to 2% of young adults.
- Detoxification treatments for opiate dependent adolescents
Cochrane Systematic Reviews, 29-Apr-2014
The scientific literature examining effective treatments for opioid dependent adults clearly indicates that pharmacotherapy is a necessary and acceptable component of effective treatments for opioid dependence. Nevertheless, no studies have been published
- Developmental care for promoting development and preventing morbidity in preterm infants
Cochrane Systematic Reviews, 10-Nov-2008
Preterm infants experience a range of morbidity related to the immaturity of their organ systems and to concurrent disease states. There is concern that an unfavourable environment in the neonatal intensive care unit (NICU) may compound this morbidity. Mo
- Dipyrone for acute primary headaches
Cochrane Systematic Reviews, 10-Jun-2019
Dipyrone is used to treat headaches in many countries, but is not available in others (particularly the USA and UK) because of its association with potentially life-threatening blood dyscrasias such as agranulocytosis.
- Distraction techniques for schizophrenia
Cochrane Systematic Reviews, 24-Jan-2005
Distraction techniques are a form of coping strategies used in cognitive behavioural techniques. They may be of value as an adjunctive treatment for people with schizophrenia or schizophrenia-like illnesses.
- Disulfiram for the treatment of cocaine dependence
Cochrane Systematic Reviews, 20-Jan-2010
Cocaine dependence is a disorder for which no pharmacological treatment of proven efficacy exists, advances in the neurobiology could guide future medication development.
- Donepezil for dementia due to Alzheimer's disease
Cochrane Systematic Reviews, 18-Jun-2018
Alzheimer's disease is the most common cause of dementia in older people. One approach to symptomatic treatment of Alzheimer's disease is to enhance cholinergic neurotransmission in the brain by blocking the action of the enzyme responsible for the breakd
- Donepezil for mild cognitive impairment
Cochrane Systematic Reviews, 19-Jul-2006
Problems with memory which do not meet the diagnostic criteria for dementia, usually called mild cognitive impairment (MCI), can be the first sign of an impending dementia, particularly Alzheimer's disease (AD). There is no consensus on a definition or di
- Donepezil for vascular cognitive impairment
Cochrane Systematic Reviews, 26-Jan-2004
Vascular disease is the second commonest cause of dementia after Alzheimer's disease. There are difficulties in classifying patients with this type of cognitive impairment owing to varied clinical presentation and different types of arterial disease. Ther
- Drama therapy for schizophrenia or schizophrenia-like illnesses
Cochrane Systematic Reviews, 23-Apr-2008
Medication is the mainstay of treatment for schizophrenia or schizophrenia-like illnesses, but many people continue to experience symptoms in spite of medication (Johnstone 1998). In addition to medication, creative therapies, such as drama therapy may pr
- Droperidol for psychosis‐induced aggression or agitation
Cochrane Systematic Reviews, 15-Dec-2016
People experiencing acute psychotic illnesses, especially those associated with agitated or violent behaviour, may require urgent pharmacological tranquillisation or sedation. Droperidol, a butyrophenone antipsychotic, has been used for this purpose in se
- Drug therapy for delirium in terminally ill adults
Cochrane Systematic Reviews, 21-Jan-2020
Delirium is a syndrome characterised by an acute disturbance of attention and awareness which develops over a short time period and fluctuates in severity over the course of the day. It is commonly experienced during inpatient admission in the terminal ph
- Drug therapy for symptoms associated with anxiety in adult palliative care patients
Cochrane Systematic Reviews, 18-May-2017
This is an update of a Cochrane Review first published in 2004 (Issue 1) and previously updated in 2012 (Issue 10). Anxiety is common in palliative care patients. It can be a natural response to the complex uncertainty of having a life-limiting illness or
- Drug treatment for faecal incontinence in adults
Cochrane Systematic Reviews, 11-Jun-2013
Faecal incontinence (leakage of bowel motions or stool) is a common symptom which causes significant distress and reduces quality of life.
- Drugs for nocturnal enuresis in children (other than desmopressin and tricyclics)
Cochrane Systematic Reviews, 12-Dec-2012
Enuresis (bedwetting) is a socially stigmatising and stressful condition which affects around 15% to 20% of five-year olds and up to 2% of young adults. Although there is a high rate of spontaneous remission, the social, emotional and psychological costs
- Drugs versus placebo for dysthymia
Cochrane Systematic Reviews, 18-Jun-2015
Dysthymia is a depressive disorder of chronic nature but of lower severity than major depression. Depressive symptoms are more or less continuous for at least two years. Patients with this disorder experience considerable social dysfunction and disability
- Duloxetine versus other anti-depressive agents for depression
Cochrane Systematic Reviews, 10-Sep-2012
Although pharmacological and psychological interventions are both effective for major depression, in primary and secondary care settings antidepressant drugs remain the mainstay of treatment. Amongst antidepressants many different agents are available. Du
- Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants
Cochrane Systematic Reviews, 24-Nov-2015
Infants born preterm are at increased risk of developing cognitive and motor impairment compared with infants born at term. Early developmental interventions have been provided in the clinical setting with the aim of improving overall functional outcomes
- Early intervention for psychosis
Cochrane Systematic Reviews, 10-Mar-2011
Proponents of early intervention have argued that outcomes might be improved if more therapeutic efforts were focused on the early stages of schizophrenia or on people with prodromal symptoms. Early intervention in schizophrenia has two elements that are
- Early psychological interventions to treat acute traumatic stress symptoms
Cochrane Systematic Reviews, 6-Dec-2011
The amelioration of psychological distress following traumatic events is a major concern. Systematic reviews suggest that interventions targeted at all of those exposed to such events are not effective at preventing post traumatic stress disorder (PTSD).
